Anthera Pharmaceuticals Inc
Biotechnology · Hayward, CA
Bayanan rajista na hukuma
0masu bi
2004an kafa
Game da Anthera Pharmaceuticals Inc
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy is currently in Phase 2 clinical trial.
Source: Wikipedia
Masana'antuBiotechnology
HedikwataHayward, CA
An kafa2004
Nau'in dokaC Corporation
MatsayiMai aiki
Haƙƙoƙin ƙirƙira1 haƙƙin ƙirƙira
PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHOLIPASE INHIBITOR SODIUM [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-1H-INDOL-4-YL]OX…JP2011021042A · 2011
Bitoci
Babu bitoci tukuna. Ka yi aiki da Anthera Pharmaceuticals Inc? Kasance na farko da zai raba gogewarsa.
Muhimman lambobi
Shiga don ganin lambobi masu mahimmanci
Kudaden shiga, ribar ƙarshe da yawan ma'aikata na Anthera Pharmaceuticals Inc a cikin shekaru, tare da tushensu.
Shiga Ƙirƙiri asusu da imel ɗinkuKyauta ne
Idan kuka ci gaba, kuna yarda da Yarjejeniyar mai amfani, Manufar sirri da Manufar kukis na Heelky.
Bayanan doka
| Sunan doka | Anthera Pharmaceuticals Inc |
|---|---|
| Nau'in doka | C Corporation |
| SEC CIK | 1316175Duba a SEC EDGAR ↗ |
| Adireshin da aka yi rajista | Hayward, CA |
| Matsayi | Mai aiki |
Tushe: SEC EDGAR · an sabunta Nov. 14, 2026
Tuntuɓa & hanyoyin haɗi
Wuri
Hayward, CA
Wannan kamfaninka ne?
Yi da'awar wannan shafi kyauta don ƙara tambari, kayayyaki, hotuna da ayyuka, da amsa bitoci.
Yi da'awar wannan shafiShiga Heelky don haɗuwa, ɗaukar ma'aikata da haɓaka
Ƙirƙiri asusu kyauta don aika wa mutane saƙo, neman ayyuka da wallafa kwangiloli.
Shiga yanzu — kyauta ne